The North America pharmacogenomics market is expected to reach US$ 6,534.83 million by 2028 from US$ 3,333.43 million in 2021. it is estimated to grow at a CAGR of 10.1% from 2021 to 2028.
The growth of the North America pharmacogenomics market is being driven by several key factors, including the rising prevalence of chronic diseases, increasing demand for precision medicine, and growing investment in pharmacogenomic research. However, a significant barrier to market expansion is the shortage of skilled professionals in the field.
A substantial portion of the elderly population—over 60%—suffers from two or more chronic conditions. Twin studies have shown that genetics play a major role in the development of chronic diseases such as cardiovascular disease (CVD), diabetes, obesity, rheumatoid arthritis (RA), Alzheimer’s disease (AD), and depression. With advancements in molecular genetics, particularly genome-wide association studies (GWAS), it is now possible to assess individual genetic risk factors for these conditions. According to the Centers for Disease Control and Prevention (CDC), as of 2020, nearly 60% of Americans had at least one chronic disease, and 40% had two or more.
Cardiovascular diseases—including atherosclerosis, angina pectoris, and acute myocardial infarction—are among the leading causes of death globally, largely driven by modern lifestyles. The World Health Organization (WHO) reports that CVDs claim approximately 17.9 million lives annually. Diabetes also poses a significant public health challenge, with no definitive cure and a wide array of serious complications, including heart attacks, strokes, kidney failure, limb amputations, vision loss, and nerve damage. The increasing number of diabetes cases is contributing to a rise in these life-altering complications. According to the International Diabetes Federation (IDF), North America had 46 million diabetic patients in 2017—a number projected to reach 62 million by 2045. Globally, diabetes cases were estimated at 425 million in 2017 and are expected to rise to 629 million by 2045, representing a projected increase of approximately 35%.
Alzheimer’s disease is another growing concern, with the Alzheimer’s Association reporting that 55 million people worldwide were affected by the condition in 2020. The escalating burden of chronic diseases has accelerated genomics research focused on developing targeted therapies, significantly fueling North America pharmacogenomics market growth in recent years.
Pharmacogenomics is increasingly being integrated into clinical practice, aided by government investments exceeding US$ 4 billion across at least 14 countries. These national genomic medicine initiatives are driving systemic change, overcoming barriers to implementation, and generating evidence to support broader adoption of pharmacogenomic approaches in healthcare.
Additionally, industry partnerships and private investments are bolstering this momentum. For example, in August 2018, Boston Scientific Corporation secured US$ 4.3 million in seed funding and partnered with Veritas Genetics to advance personal genome sequencing. The initiative aims to build a secure, decentralized marketplace for genomic data, reflecting the broader trend of sustained investment by both manufacturers and governments in genomics—further propelling the growth of the North America pharmacogenomics market.
North America Pharmacogenomics Market Segmentation
North America pharmacogenomics market By Technology
- Hospitals & Clinics
- Biopharmaceutical Companies
- CROs and CDMOs
- Others
North America pharmacogenomics market By Application
- PCR
- Sequencing
- Microarray
- gel electrophoresis
- mass spectrometry
- Others
North America pharmacogenomics market By End User
- Drugs Discovery
- Oncology
- Neurological & Psychiatry
- Pain Management
- Cardiovascular
- Others
North America pharmacogenomics market By Country
- US
- Canada
- Mexico
North America pharmacogenomics market Company Profiles
- Abbott
- F. HOFFMANN-LA ROCHE LTD.
- Oxford Nanopore Technologies
- THERMO FISHER SCIENTIFIC INC.
- Illumina, Inc.
- QIAGEN
- Agilent Technologies, Inc.
- Myriad Genetics, Inc.
- Admera Healt
North America pharmacogenomics market Strategic Insights
Strategic insights for the North America pharmacogenomics market provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the North America pharmacogenomics market.
North America pharmacogenomics market Regional Insights
The geographic scope of the North America pharmacogenomics market refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Other Reports:
North America Bathroom Vanities Market: https://business-news-insights.blogspot.com/2025/05/north-america-bathroom-vanities-market.html
North America Botulinum Toxin Market: https://sites.google.com/view/botulinum-toxin-market-na/home
North America Laboratory Information Management Systems (LIMS) Market: https://write.as/25gyu2djhayz2one.md
North America Synthetic Leather Market: https://medium.com/@sng214821/north-america-synthetic-leather-market-key-segments-emerging-scenario-forecast-to-2028-57b8badf47ba
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
